Influence of blood pressure variability on the life of arteriovenous fistulae in maintenance hemodialysis patients. 2016

Yue Cheng, and Fan Zhang, and Jun Zhu, and Tao Wang, and Meng Wei, and Dongyang Guo, and Liweng Mo, and Changliang Zhu, and Xia Wang

BACKGROUND Although numerous risk factors for arteriovenous fistulae (AVF) dysfunction have been identified, these risk factors do not explain all cases of AVF dysfunction. Because of the importance of blood pressure variability (BPV) in vascular injury, the predictive value of BPV for AVF dysfunction, was evaluated in this prospective cohort study. METHODS Twenty-four-hour BP monitoring at the intervals of dialysis was recorded every 3 months in 137 patients. The expression of smooth muscle actin (SMA) and the infiltration of mononuclear cells and T lymphocytes were determined by immunohistochemistry on the specimens of fistula vessels. RESULTS Eighteen patients developed AVF dysfunction. Cox proportional hazards multivariate analysis revealed a significant relationship between fistula dysfunction and daytime systolic-BPV (d-SBPV), nighttime systolic-BPV (n-SBPV), diabetes mellitus, and initial venous diameter. Patients with AVF dysfunction were observed to have increased SMA expression and more infiltration of inflammatory cells in venous walls compared with the controls. A significant correlation between SBPV and the infiltration of CD68-positive cells was observed. CONCLUSIONS Our study showed that the degrees of SBPV were significantly associated with the risk of AVF dysfunction. Potentially, the increase of SBPV will aggravate venous wall inflammation and may play a role in AVF dysfunction.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses

Related Publications

Yue Cheng, and Fan Zhang, and Jun Zhu, and Tao Wang, and Meng Wei, and Dongyang Guo, and Liweng Mo, and Changliang Zhu, and Xia Wang
March 2021, International journal of clinical practice,
Yue Cheng, and Fan Zhang, and Jun Zhu, and Tao Wang, and Meng Wei, and Dongyang Guo, and Liweng Mo, and Changliang Zhu, and Xia Wang
January 1969, Nephron,
Yue Cheng, and Fan Zhang, and Jun Zhu, and Tao Wang, and Meng Wei, and Dongyang Guo, and Liweng Mo, and Changliang Zhu, and Xia Wang
September 2023, Panminerva medica,
Yue Cheng, and Fan Zhang, and Jun Zhu, and Tao Wang, and Meng Wei, and Dongyang Guo, and Liweng Mo, and Changliang Zhu, and Xia Wang
January 2007, Blood purification,
Yue Cheng, and Fan Zhang, and Jun Zhu, and Tao Wang, and Meng Wei, and Dongyang Guo, and Liweng Mo, and Changliang Zhu, and Xia Wang
July 1980, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
Yue Cheng, and Fan Zhang, and Jun Zhu, and Tao Wang, and Meng Wei, and Dongyang Guo, and Liweng Mo, and Changliang Zhu, and Xia Wang
January 1973, Nephron,
Yue Cheng, and Fan Zhang, and Jun Zhu, and Tao Wang, and Meng Wei, and Dongyang Guo, and Liweng Mo, and Changliang Zhu, and Xia Wang
June 2013, Zhonghua nei ke za zhi,
Yue Cheng, and Fan Zhang, and Jun Zhu, and Tao Wang, and Meng Wei, and Dongyang Guo, and Liweng Mo, and Changliang Zhu, and Xia Wang
January 2020, Journal of biological regulators and homeostatic agents,
Yue Cheng, and Fan Zhang, and Jun Zhu, and Tao Wang, and Meng Wei, and Dongyang Guo, and Liweng Mo, and Changliang Zhu, and Xia Wang
November 1984, Clinical nephrology,
Yue Cheng, and Fan Zhang, and Jun Zhu, and Tao Wang, and Meng Wei, and Dongyang Guo, and Liweng Mo, and Changliang Zhu, and Xia Wang
March 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Copied contents to your clipboard!